These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 9382773
1. Induction of immunity by DNA vaccination: application to influenza and tuberculosis. Ulmer JB, Deck RR, DeWitt CM, Donnelly JJ, Friedman A, Montgomery DL, Yawman AM, Orme IM, Denis O, Content J, Huygen K, Liu MA. Behring Inst Mitt; 1997 Feb; (98):79-86. PubMed ID: 9382773 [Abstract] [Full Text] [Related]
2. [Novel vaccines against M. tuberculosis]. Okada M. Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [Abstract] [Full Text] [Related]
4. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z. J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973 [Abstract] [Full Text] [Related]
10. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein. Fonseca DP, Benaissa-Trouw B, van Engelen M, Kraaijeveld CA, Snippe H, Verheul AF. Infect Immun; 2001 Aug 10; 69(8):4839-45. PubMed ID: 11447158 [Abstract] [Full Text] [Related]
11. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Romano M, D'Souza S, Adnet PY, Laali R, Jurion F, Palfliet K, Huygen K. Vaccine; 2006 Apr 12; 24(16):3353-64. PubMed ID: 16488518 [Abstract] [Full Text] [Related]
12. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein. James CM, Abdad MY, Mansfield JP, Jacobsen HK, Vind AR, Stumbles PA, Bartlett EJ. Vaccine; 2007 Feb 26; 25(10):1856-67. PubMed ID: 17240000 [Abstract] [Full Text] [Related]
14. Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. Epstein SL, Kong WP, Misplon JA, Lo CY, Tumpey TM, Xu L, Nabel GJ. Vaccine; 2005 Nov 16; 23(46-47):5404-10. PubMed ID: 16011865 [Abstract] [Full Text] [Related]
15. Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination. Chen Y, Webster RG, Woodland DL. J Immunol; 1998 Mar 01; 160(5):2425-32. PubMed ID: 9498786 [Abstract] [Full Text] [Related]
16. Antiviral immunity induced by recombinant nucleoprotein of influenza A virus. I. Characteristics and cross-reactivity of T cell responses. Tite JP, Russell SM, Dougan G, O'Callaghan D, Jones I, Brownlee G, Liew FY. J Immunol; 1988 Dec 01; 141(11):3980-7. PubMed ID: 3263440 [Abstract] [Full Text] [Related]
17. Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c). Romano M, Rindi L, Korf H, Bonanni D, Adnet PY, Jurion F, Garzelli C, Huygen K. Vaccine; 2008 Nov 11; 26(48):6053-63. PubMed ID: 18822333 [Abstract] [Full Text] [Related]
18. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. Wang D, Christopher ME, Nagata LP, Zabielski MA, Li H, Wong JP, Samuel J. J Clin Virol; 2004 Dec 11; 31 Suppl 1():S99-106. PubMed ID: 15567101 [Abstract] [Full Text] [Related]